Yu-Guang Li Selected Research

Acupuncture Points (Acupuncture Point)

6/2015

Effects of electroacupuncture on corticotropin-releasing hormone in rats with chronic visceral hypersensitivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Guang Li Research Topics

Disease

7	Neoplasms (Cancer) 01/2019 - 05/2007
5	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 09/2014
2	Carcinogenesis 01/2019 - 10/2016
2	Hepatocellular Carcinoma (Hepatoma) 06/2018 - 11/2017
2	Neoplasm Metastasis (Metastasis) 05/2018 - 01/2018
2	Vascular Remodeling 12/2011 - 06/2008
2	Coronary Disease (Coronary Heart Disease) 01/2009 - 06/2006
2	Lung Neoplasms (Lung Cancer) 06/2008 - 05/2007
2	Shock 02/2006 - 06/2005
1	Disease Progression 05/2018
1	Adenocarcinoma of Lung 05/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Lymphoma (Lymphomas) 01/2018
1	Lung Injury 12/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2015
1	Hypersensitivity (Allergy) 06/2015
1	Hyperalgesia 06/2015
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 06/2015
1	Neuroblastoma 02/2014
1	Rare Diseases (Rare Disease) 01/2014
1	Leukemia 05/2013
1	Inflammation (Inflammations) 03/2009
1	Hypoxia (Hypoxemia) 01/2009
1	Hypertrophy 01/2007
1	Body Weight (Weight, Body) 01/2007
1	Fibrosis (Cirrhosis) 01/2007
1	Cardiomegaly (Heart Hypertrophy) 01/2007
1	Atherosclerosis 01/2006

Drug/Important Bio-Agent (IBA)

6	MicroRNAs (MicroRNA)IBA 01/2019 - 09/2014
5	Messenger RNA (mRNA)IBA 06/2018 - 01/2007
5	Long Noncoding RNAIBA 01/2018 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2009
4	Biomarkers (Surrogate Marker)IBA 11/2017 - 01/2007
3	urotensin IIIBA 12/2011 - 01/2007
2	Circular RNAIBA 11/2018 - 01/2018
2	RNA (Ribonucleic Acid)IBA 05/2018 - 01/2018
2	Small Interfering RNA (siRNA)IBA 10/2016 - 09/2014
2	NF-kappa B (NF-kB)IBA 03/2009 - 02/2006
2	Heme Oxygenase-1IBA 01/2009 - 02/2006
1	Biological ProductsIBA 05/2018
1	Progesterone FDA LinkGeneric 01/2018
1	AntigensIBA 10/2016
1	Transcription Factors (Transcription Factor)IBA 10/2016
1	SmokeIBA 12/2015
1	Corticotropin-Releasing HormoneIBA 06/2015
1	E2F1 Transcription FactorIBA 02/2014
1	N-Myc Proto-Oncogene ProteinIBA 02/2014
1	Arsenic Trioxide (Trisenox)FDA Link 05/2013
1	human MIRN203 microRNAIBA 05/2013
1	OsteopontinIBA 12/2011
1	Testosterone (Sustanon)FDA Link 03/2009
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 03/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2009
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2009
1	UbiquitinIBA 01/2009
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2008
1	CalcineurinIBA 06/2008
1	CollagenIBA 06/2008
1	Mitogen-Activated Protein KinasesIBA 06/2008
1	rho-Associated KinasesIBA 06/2008
1	Protein Kinase CIBA 06/2008
1	Cyclin D1IBA 05/2007
1	Malondialdehyde (Propanedial)IBA 01/2007
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2007
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2007
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2007
1	Peptides (Polypeptides)IBA 01/2007
1	Heme (Haem)IBA 06/2006
1	LipopolysaccharidesIBA 02/2006
1	Matrix Metalloproteinases (MMPs)IBA 01/2006
1	CD40 Ligand (CD40L)IBA 01/2006
1	Sincalide FDA Link 06/2005

Therapy/Procedure

1	Transplantation 12/2015
1	Acupuncture Points (Acupuncture Point) 06/2015
1	Electroacupuncture 06/2015
1	Aftercare (After-Treatment) 06/2015
1	Drug Therapy (Chemotherapy) 09/2014
1	Therapeutics 01/2009